BPC-157 does not suppress natural hormone production, require post-cycle therapy, or demonstrate rebound effects, but periodic breaks allow the body to consolidate healing and reduce theoretical receptor desensitization risks
Ideal For: Patients with: Leaky Gut Syndrome, IBS, IBD (Crohns, Ulcerative Colitis), acid reflux, stomach ulcers, or general digestive inflammation
When should I start adding peptides to my Retatrutide protocol
Under 150 lbs or Over 250 lbs Most peptide protocols use fixed dosing, not weight-based dosing
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal [PMID: 36432602] Laboratory literature summary: NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions
There was no placebo group, blinding or untreated comparison, and the observation lasted three days